经动脉化学栓塞和经皮冷冻序贯治疗肝细胞癌/Treatment of hepatocellular carcinoma with transarterial chemoembolization and percutaneous cryourgery
XU Kecheng, NIU Lizhi, ZHOU Qiang et al.
【摘要】
目的: 评价经动脉化学检塞(TACE)和经皮冷冻序贯治疗无法切除的肝细胞肝癌(HCC)的疗效。
方法: 将420例无法手术切除的HCC患者分为TACE一冷冻序贯治疗组290例(序贯组)和单纯冷冻组130例(冷冻组)。TACE按常规操作,术后2~4周行经皮冷冻治疗。1个月及以后每2~3个月随访1次。包括肝脏超声和(或)腹部CT,并检测血清甲胎蛋白(AFP)。
结果: 平均随访(42士17)个月(范围24~70个月),所有患者消融灶局部复发率为17%,序贯组和冷冻组分别为1l%和24%(P一0.001)。1、2、3、4和5年平均存活率分别为72%、57%、47%、39%和3l%。序贯组1年和2年存活率(71%和61%)与冷冻组(73%和54%)相似(P值分别=0.69和0.147);而4年和5年存活率,序贯组(49%和39%)高于冷冻组(21%和23%,P=0.001)。序贯组有18例肿瘤直径>5cm的患者存活逾5年。而冷冻组无一例。全组并发症发生率为24%,序贯组和冷冻组分别为21%和26%(P=0.06)。冷冻组肝出血的发生率显著高于序贯组(P=0.02),且有2例发生肝破裂。
结论: 冷冻治疗前先行TACE能提高冷冻消融的疗效,减少其并发症,特别是肝出血。TACE和冷冻序贯疗法可能是治疗不能切除性HCC,特别是大肝癌的较好方法。
【关键词】肝细胞癌;冷冻治疗;经动脉化学栓塞;冷消融;治疗
[Abstraa]
0bjective To evaluate the efficacy of transarterial chemoembolization(TACE)and percutaneous cryosurgery sequential therapy for unresectable hepatocellular carcinoma(HCC).
Methods Four hundred and twenty patients with unresectable HCC were divided into sequential TACE-cryosurgery sequential(sequential)group(n=290)and cryosurgery alone(cryoalone)group (n=130).TACE was perfcIrmed with the routine operation;the percutaneous cryosurgery was conducted 2 to 4 weeks after TACE.Thepatients were followed up at the first month and once every
2 to 3 month later.Liver ultrasound or both computer tomography and alpha fetal protein were examined during follow-up.Results During a mean follow-up of(42士1 7)months(range from 24 to 70 months),the local recurrence rate of ablated lesion was 1 7%for all the patients,11%and 24%for patients in sequential group and cryoalone groups respectively(P=O.00 1).The overall 1-。2-,3-,4- and 5-year survival rate was 72%,57%,47%,39%and 31%,respectively.The l-and 2-year survival rates(71% and 61%)in sequential group were similar to those(73%and 54%)in cryo-alone group(P=0.69 and 0.147),while the 4-and 5-year survival rates were higher in sequential group (49%and 39%)than those(29%and z3%)in cryo-alone group(P=0.001).Eighteen patients with large HCC(>5 cm in diameter)in sequential group survived for more than 5 years while no one in cryo-alone group.Complication rate was 24%in all patients,21%and 26%for the sequential and cryo-alone groups respectively(P=0.06).The incidence of hepatic bleeding was higher in cryo-alone group than in sequential group(P=0.02).Liver crack occurred in two patients of the cryoalone group.
Conclusions Pre-cryosurgical TACE increased the cryoablation efficacy and decrease its complications,especially hepatic bleeding.TACE and cryosurgery sequential therapy may be a better treatment for unresectable HCC, especially for large HCC.
[Key words] Carcinoma,hepatocellular;Cryosurgery;Transarterial chemoembolization; Cryoablation;Treatment